Skip to main content
TXG
NASDAQ Industrial Applications And Services

10x Genomics Reports Sharply Reduced Q1 Net Loss, Improved Margins, and Key Legal Win

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$21.46
Mkt Cap
$2.892B
52W Low
$7.72
52W High
$26.445
52W Position info
178% above low
Off High info
19% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

TXG has more than doubled off its 52-week low of $7.72.

Summary

10x Genomics reported a significantly reduced net loss and improved gross margin in Q1 2026, alongside strong product revenue growth and a favorable patent infringement ruling in Europe.


Key Events · Earnings and Guidance · TXG

  • Net Loss Significantly Reduced

    The company reported a net loss of $13.5 million for Q1 2026, a substantial improvement from a net loss of $34.4 million in Q1 2025, reflecting strong cost management and operational efficiency.

  • Gross Margin Improvement

    Gross margin increased to 70% in Q1 2026, up from 68% in the prior-year quarter, primarily due to lower inventory write-downs and reduced warranty costs.

  • Core Product Revenue Growth

    Products and services revenue increased by 9% to $149.9 million, driven by a 13% increase in consumables revenue, with spatial consumables growing 31% year-over-year. Total revenue decreased 3% due to a non-recurring $16.8 million license revenue in Q1 2025.

  • Operating Expenses Cut

    Total operating expenses decreased by 15% to $123.2 million, with research and development down 12% and selling, general and administrative expenses down 26%, demonstrating effective cost control.


Analysis · TXG · Industrial Applications And Services

This 10-Q filing details a strong operational quarter for 10x Genomics, building on the preliminary Q1 results announced in the recent 8-K. The company significantly narrowed its net loss by over 60% year-over-year, driven by substantial reductions in operating expenses and an improved gross margin. While total revenue saw a slight decline due to a non-recurring license payment in the prior year, core products and services revenue demonstrated healthy growth, particularly in spatial consumables. A notable legal victory, a permanent injunction against a competitor in Europe, reinforces the company's intellectual property position. The company maintains a robust cash position, providing ample liquidity for future operations and strategic initiatives. Investors should view these results as a positive indicator of operational efficiency and market strength in key product areas.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TXG was trading at $21.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $7.72 to $26.45. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TXG - Latest Insights

TXG
Nov 05, 2026, 5:35 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $57.61
Real-time Price: $56.68 info
Change: -$0.930 (-2%) info
Market Cap: $7.547B info
TXG
Nov 05, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $57.72
Real-time Price: $56.68 info
Change: -$1.04 (-2%) info
Market Cap: $7.547B info
TXG
Sep 29, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $89.46
Real-time Price: $56.68 info
Change: -$32.78 (-37%) info
Market Cap: $7.547B info
TXG
Aug 06, 2026, 5:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $43.07
Real-time Price: $56.68 info
Change: +$13.61 (+32%) info
Market Cap: $7.547B info
TXG
Jun 09, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $29.50
Real-time Price: $56.68 info
Change: +$27.18 (+92%) info
Market Cap: $7.547B info